These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4214664)

  • 21. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
    Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
    Sov Med; 1984; (1):83-7. PubMed ID: 6701660
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of halofenate on exercise performance in coronary heart disease.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP
    Clin Pharmacol Ther; 1973; 14(3):366-70. PubMed ID: 4698564
    [No Abstract]   [Full Text] [Related]  

  • 23. A two-year crossover therapeutic trial with halofenate and clofibrate.
    Dujovne CA; Azarnoff DL; Pentikainen P; Manion C; Hurwitz A; Hassanein K
    Am J Med Sci; 1976; 272(3):277-84. PubMed ID: 797258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Contribution to the study of blood uric acid in normal individuals: correlation between blood cholesterol, triglycerides, total lipids, sugar and free fatty acids].
    Godoy M; Giannini SD; Diament J; Forti N; Thomè O; Papaléo Neto M; Stellin JA; Coelho LT; Paula e Silva P
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(1):15-22. PubMed ID: 5553898
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directional trends in serum uric acid and lipids in 865 Spnnish-and Anglo-American men and women, age 20-79 years.
    Shields LM; Sansoy OM; Mortimer R
    Southwest Med; 1971 Mar; 52(3):54-7. PubMed ID: 5554571
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate decreases plasma fibrinogen, improves lipid profile, and reduces uricemia.
    de la Serna G; Cadarso C
    Clin Pharmacol Ther; 1999 Aug; 66(2):166-72. PubMed ID: 10460070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of physical exercise on serum cholesterol, triglyceride and uric acid levels in patients with chronic coronary failure].
    Halawa B
    Wiad Lek; 1979 Mar; 32(5):293-8. PubMed ID: 442664
    [No Abstract]   [Full Text] [Related]  

  • 31. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
    Weber E; Walter E; Pfleiderer T
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
    [No Abstract]   [Full Text] [Related]  

  • 32. Halofenate. Its selection and trial as a primary uricosuric agent.
    Bluestone R; Campion D; Klinenberg JR
    Arthritis Rheum; 1975; 18(6 Suppl):859-62. PubMed ID: 1106434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in blood chemistries following a controlled exercise program.
    Altekruse EB; Wilmore JH
    J Occup Med; 1973 Feb; 15(2):110-3. PubMed ID: 4685420
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum lipids in normal subjects, coronary heart disease and cerebrovascular disease.
    Rattanapanone V; Jiviriyawat Y
    J Med Assoc Thai; 1983 Dec; 66(12):779-84. PubMed ID: 6676441
    [No Abstract]   [Full Text] [Related]  

  • 35. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the blood components considered as risk predictors in coronary heart disease.
    Hoschoian JC; Catz SD; Borruel MA; Wikinski RL; Rodríguez MP
    Medicina (B Aires); 1993; 53(1):13-20. PubMed ID: 8246725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites.
    Schlosstein LH; Kippen I; Whitehouse MW; Bluestone R; Paulus HE; Klinenberg JR
    J Lab Clin Med; 1973 Sep; 82(3):412-8. PubMed ID: 4740876
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.